132 Annual Meeting Logo - Go to APHA Meeting Page  
APHA Logo - Go to APHA Home Page
Session: IDU's, HCV, and HIV
4330.0: Tuesday, November 9, 2004: 8:30 PM-10:00 PM
IDU's, HCV, and HIV
Learning Objectives: See individual abstracts.
Moderator(s):Richard S. Garfein, PhD, MPH
8:30 PMPredictors of cessation of injection drug use among Puerto Rican drug injectors in NYC  [ Recorded presentation ]
Sherry Deren, PhD, Sung-Yeon Kang, PhD, Héctor M. Colón, PhD, Rafaela R. Robles, EdD
8:48 PMWithdrawn -- Preventing HCV and HIV infections among IDUs in New York City, 1990-2002
Don C. Des Jarlais, PhD, Theresa Perlis, PhD, L ucia V. Torian, PhD, Kaymar Arasteh, PhD, Sara Beatrice, Judith Wethers, MS, Lou Smith, MD, Donna Mildvan, MD, Stanley Yancovitz, MD, Samuel R. Friedman, PhD
9:06 PMDemographic characteristics, drug use behaviors, and risk reduction beliefs of young injection drug users (IDUs) and their parents in suburban Chicago  [ Recorded presentation ]
Matthew J. Magee, BA, Susan L. Bailey, PhD, Lawrence J. Ouellet, PhD
9:24 PMDemographic characteristics, risk behaviors and HIV/HCV seroprevelance of young non-injecting heroin users in Chicago  [ Recorded presentation ]
Dita Broz, MPH, Susan L. Bailey, PhD, Lawrence J. Ouellet, PhD
9:42 PMUnexpectedly low HIV and HCV prevalence in young injectors in a US multi-site study  [ Recorded presentation ]
Steffanie A. Strathdee, PhD, Holly Hagan, PhD, David Vlahov, PhD, Sharon M. Hudson, PhD, SL Bailey, Peter O'Driscoll, MS, Richard Garfein, PhD
See individual abstracts for presenting author's disclosure statement and author's information.
Organized by:Alcohol, Tobacco, and Other Drugs
Endorsed by:HIV/AIDS
CE Credits:CME, Health Education (CHES), Nursing

The 132nd Annual Meeting (November 6-10, 2004) of APHA